Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]
- PMID: 33958898
- PMCID: PMC8096412
- DOI: 10.2147/HIV.S316675
Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]
Abstract
[This retracts the article DOI: 10.2147/HIV.S300135.].
© 2021 Dove Medical Press.
Retraction of
-
Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia.HIV AIDS (Auckl). 2021 Mar 16;13:307-314. doi: 10.2147/HIV.S300135. eCollection 2021. HIV AIDS (Auckl). 2021. Retraction in: HIV AIDS (Auckl). 2021 Apr 30;13:475. doi: 10.2147/HIV.S316675. PMID: 33758553 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
